Both in Pharmaceuticals
Lipocine vs AEON Biopharma
Over the past year LPCN returned −45.1% and AEON returned −71.6%; their daily moves had a correlation of 0.11.
LPCN −45.1% AEON −71.6%Growth of $1, one year, split-adjusted
| Metric | LPCN | AEON |
|---|---|---|
| Price | $1.51 | $0.2640 |
| Market cap | $12.4M | $15.6M |
| Today | +3.42% | +6.32% |
| 1 month | −30.1% | +1.9% |
| 6 months | −34.1% | −72.3% |
| Year to date | −81.2% | −76.0% |
| 1 year | −46.5% | −71.0% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 9.9× | — |
| Net cash | $23.3M | $743.0K |
| Dividend yield | — | — |
| Volatility (60d) | 56.7% | 114.4% |
| Short % of float | 4.6% | 28.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).